CECILIA THOMPSON: Open Payments
NPI 1144885880 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 23 payments from 5 companies in 2025. Trend: 2023 $381 · 2024 $614 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $212 |
| ABBVIE INC. | 6 | $106 |
| Janssen Biotech, Inc. | 2 | $31 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: XELJANZ, RINVOQ, VELSIPITY, TREMFYA, REZDIFFRA, XIFAXAN, SKYRIZI, MAVYRET.
Industry payments across AL — which companies pay providers there.
